Envista Holdings Co. (NYSE:NVST) Holdings Raised by Natixis Advisors LLC

Natixis Advisors LLC lifted its stake in Envista Holdings Co. (NYSE:NVST) by 21.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 104,807 shares of the company’s stock after acquiring an additional 18,699 shares during the quarter. Natixis Advisors LLC owned approximately 0.06% of Envista worth $2,071,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of NVST. Price T Rowe Associates Inc. MD boosted its stake in shares of Envista by 6.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,887 shares of the company’s stock worth $2,863,000 after acquiring an additional 8,380 shares in the last quarter. Invenomic Capital Management LP lifted its holdings in Envista by 24.9% during the 1st quarter. Invenomic Capital Management LP now owns 481,558 shares of the company’s stock valued at $10,296,000 after purchasing an additional 96,090 shares during the last quarter. Tidal Investments LLC grew its position in Envista by 105.1% during the 1st quarter. Tidal Investments LLC now owns 20,331 shares of the company’s stock worth $435,000 after acquiring an additional 10,420 shares during the last quarter. Swedbank AB bought a new stake in shares of Envista during the first quarter worth $53,412,000. Finally, Versant Capital Management Inc increased its position in Envista by 1,420.3% in the 2nd quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock valued at $52,000 after acquiring an additional 2,940 shares in the last quarter.

Envista Stock Up 0.4 %

Shares of NYSE NVST opened at $21.48 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. The stock has a market capitalization of $3.70 billion, a P/E ratio of -2.76, a PEG ratio of 2.98 and a beta of 1.30. The stock’s fifty day moving average is $19.48 and its 200 day moving average is $18.17. Envista Holdings Co. has a 52 week low of $15.15 and a 52 week high of $25.64.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. During the same period last year, the firm posted $0.43 earnings per share. Envista’s revenue was down 4.8% compared to the same quarter last year. Sell-side analysts forecast that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on NVST shares. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Robert W. Baird increased their price target on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. JPMorgan Chase & Co. lowered shares of Envista from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $23.00 to $16.00 in a research note on Thursday, August 8th. Bank of America lowered their price objective on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. Finally, Piper Sandler upped their target price on Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Envista presently has an average rating of “Hold” and a consensus price target of $20.71.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.